Same Drug Class

Methotrexate vs Upadacitinib

Methotrexate vs Upadacitinib: Overview

This comparison examines the pharmacological differences between Methotrexate and Upadacitinib.

Mechanism of Action

Methotrexate: Dihydrofolate reductase inhibitor.

Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.

Pharmacokinetics

Half-life: Methotrexate β€” 3-10 hours; Upadacitinib β€” 9-14 hours.

Chemical Properties

Molecular Formula: Methotrexate β€” C20H22N8O5; Upadacitinib β€” C17H19F3N6O.

Molecular Weight: Methotrexate β€” 454.4400 g/mol; Upadacitinib β€” 380.3700 g/mol.

Type: Methotrexate β€” Small molecule; Upadacitinib β€” Small molecule.